Europe:+32-2-535-7543
Asia: +65-6223-2436
Int'l: +1-860-674-8796
US: +1-866-353-3335
  • Japanese
  • Korean
  • Chinese
Cover Image

Global Minimally Invasive Vertebral Compression Fracture (VCF) Repair Market 2015-2019

About VCF

VCF is characterized by the collapse of one or more vertebral bodies, resulting in insistent and unbearable pain in patients. Osteoporosis, a degenerative bone disease, is the major cause of VCF among the elderly women. Metastatic spinal tumors, multiple myeloma, metastatic bone disease, and traumatic injuries are other causes of VCF. Individuals with VCF can undergo vertebroplasty and kyphoplasty to rectify the condition. Both procedures are minimally invasive and conducted on an outpatient basis. The use of two balloon devices makes kyphoplasty stand apart from vertebroplasty. The insertion and gradual inflation of these devices help restore the pre-facture shape and height of the vertebral bodies. Both these vertebral augmentation procedures lead to long-term maintenance of spinal bones injured by compression fractures, irrespective of their source. These procedures reduce pain in individuals, lessen the need for pain medications, decrease dependence on canes or other supporting devices, and help return to a relatively normal level of physical activity.

Technavio's analysts forecast the global minimally invasive vertebral compression fracture repair market to grow at a CAGR of 10.36% over the period 2015-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the global minimally invasive vertebral compression fracture repair market for the period 2015-2019. To calculate the market size, the report considers revenue generated through different types of minimally invasive procedures. The report presents the vendor landscape and a corresponding detailed analysis of the top six vendors in the market.

Technavio's report, Global Minimally Invasive Vertebral Compression Fracture Repair Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Alphatec Holdings
  • CareFusion
  • DePuy Synthes
  • Medtronic
  • Stryker
  • Zimmer

Other Prominent Vendors

  • AOI Medical
  • Benvenue Medical
  • Biomet
  • Bonesupport
  • Cook Medical
  • Crosstrees Medical
  • DFine
  • Global Medical
  • Vexim
  • Zavation

Market Driver

  • Growing Aging Population
  • For a full, detailed list, view our report

Market Challenge

  • High Cost of VCF Surgeries
  • For a full, detailed list, view our report

Market Trend

  • Growing Medical Tourism in Developing Countries
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. VCFs

07. Market Landscape

  • 07.1. Market Overview
  • 07.2. Market Size and Forecast
  • 07.3. Five Forces Analysis

08. Market Segmentation by Technology

  • 08.1. Global Vertebroplasty Market
    • 08.1.1. Market Size and Forecast
    • 08.1.2. Global Vertebroplasty Market by Number of Procedures
  • 08.2. Global Kyphoplasty Market
    • 08.2.1. Market Size and Forecast
    • 08.2.2. Global Kyphoplasty Market by Number of Procedures

09. Complications Associated with Vertebroplasty and Kyphoplasty

10. Cost Analysis

11. Reimbursement Scenario

  • 11.1. Reimbursement Scenario in US
    • 11.1.1. Codes and Payments for Outpatient Procedures (Hospitals)
    • 11.1.2. Codes and Payment for Outpatient Procedures at ASC
    • 11.1.3. Physician Payments for Procedures Performed at Hospital or ASC
    • 11.1.4. Physician Payments for Procedures Performed in a Physician Office (Non-facility Setting)
  • 11.2. Reimbursement Scenario in Other Major Countries
    • 11.2.1. UK
    • 11.2.2. Germany
    • 11.2.3. Spain
    • 11.2.4. Italy
    • 11.2.5. France
    • 11.2.6. Japan

12. Geographical Segmentation

  • 12.1. Minimally Invasive VCF Repair Market in Americas
    • 12.1.1. Market Size and Forecast
  • 12.2. Minimally Invasive VCF Repair Market in EMEA
    • 12.2.1. Market Size and Forecast
  • 12.3. Minimally Invasive VCF Repair Market in APAC
    • 12.3.1. Market Size and Forecast

13. Key Leading Countries

  • 13.1. US
  • 13.2. Germany
  • 13.3. Japan

14. Buying Criteria

15. Market Growth Drivers

16. Drivers and Their Impact

17. Market Challenges

18. Impact of Drivers and Challenges

19. Market Trends

20. Trends and Their Impact

21. Vendor Landscape

  • 21.1. Competitive Scenario
    • 21.1.1. Key News
    • 21.1.2. Mergers and Acquisitions
  • 21.2. Market Share Analysis 2014
  • 21.3. Other Prominent Vendors

22. Key Vendor Analysis

  • 22.1. Alphatec
    • 22.1.1. Key Facts
    • 22.1.2. Business Overview
    • 22.1.3. Geographical Segmentation by Revenue 2014
    • 22.1.4. Business Strategy
    • 22.1.5. Recent Developments
    • 22.1.6. SWOT Analysis
  • 22.2. CareFusion Corp.
    • 22.2.1. Key Facts
    • 22.2.2. Business Overview
    • 22.2.3. Business Segmentation
    • 22.2.4. Business Segmentation by Revenue 2012 and 2013
    • 22.2.5. Sales by Geography
    • 22.2.6. Business Strategy
    • 22.2.7. Key Information
    • 22.2.8. SWOT Analysis
    • 22.2.9. Strengths
    • 22.2.10. Weaknesses
    • 22.2.11. Opportunities
    • 22.2.12. Threats
  • 22.3. DePuy Synthes
    • 22.3.1. Key Facts
    • 22.3.2. Business Overview
    • 22.3.3. Business Segmentation
    • 22.3.4. Business Strategy
    • 22.3.5. Recent Developments
    • 22.3.6. SWOT Analysis
  • 22.4. Medtronic
    • 22.4.1. Key Facts
    • 22.4.2. Business Overview
    • 22.4.3. Key Products
    • 22.4.4. Business Segmentation by Revenue 2014
    • 22.4.5. Cardiac and Vascular Group Segmentation by Revenue 2014
    • 22.4.6. Restorative Therapies Group Segmentation by Revenue 2014
    • 22.4.7. Diabetes Group Segmentation by Revenue 2014
    • 22.4.8. Business Segmentation by Revenue 2013 and 2014
    • 22.4.9. Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014
    • 22.4.10. Restorative Therapies Group Segmentation by Revenue 2013 and 2014
    • 22.4.11. Diabetes Group Segmentation by Revenue 2013 and 2014
    • 22.4.12. Geographical Segmentation by Revenue 2014
    • 22.4.13. Business Strategy
    • 22.4.14. Key Developments
    • 22.4.15. SWOT Analysis
  • 22.5. Stryker
    • 22.5.1. Key Facts
    • 22.5.2. Business Overview
    • 22.5.3. Business Segmentation by Revenue 2013
    • 22.5.4. Business Segmentation by Revenue 2012 and 2013
    • 22.5.5. Geographical Segmentation by Revenue 2013
    • 22.5.6. Business Strategy
    • 22.5.7. Recent Developments
    • 22.5.8. SWOT Analysis
  • 22.6. Zimmer Holdings
    • 22.6.1. Key Facts
    • 22.6.2. Business Overview
    • 22.6.3. Business Segmentation by Revenue 2013
    • 22.6.4. Business Segmentation by Revenue 2012 and 2013
    • 22.6.5. Geographical Segmentation by Revenue 2013
    • 22.6.6. Business Strategy
    • 22.6.7. Recent Developments
    • 22.6.8. SWOT Analysis

23. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Observed and Expected Survival Rate Following VCF in Men and Women Aged ≥ 65 Years
  • Exhibit 3: Exhibit 5: Global Minimally Invasive VCF Repair Market 2014-2019 ($ million)
  • Exhibit 4: Global Minimally Invasive VCF Repair Market Segmentation by Technology
  • Exhibit 5: Various Steps in Vertebroplasty Procedure
  • Exhibit 6: Various Steps in Kyphoplasty Procedure
  • Exhibit 7: Segmentation of Global Minimally Invasive VCF Repair Market by Technology 2014-2019
  • Exhibit 8: Global Vertebroplasty Market 2014-2019 ($ million)
  • Exhibit 9: Number of Vertebroplasty Procedures 2014-2019
  • Exhibit 10: Global Kyphoplasty Market 2014-2019 ($ million)
  • Exhibit 11: Number of Kyphoplasty Procedures 2014-2019
  • Exhibit 12: Market Share Analysis for Vertebroplasty and Kyphoplasty
  • Exhibit 13: Complication Rates of Vertebroplasty and Kyphoplasty
  • Exhibit 14: Global Average Cost of Vertebroplasty Procedure
  • Exhibit 15: Global Average Cost of Kyphoplasty Procedure
  • Exhibit 16: Segmentation of Global Minimally Invasive VCF Repair Market by Geography 2014
  • Exhibit 17: Minimally Invasive VCF Repair Market in Americas 2014-2019 ($ million)
  • Exhibit 18: Minimally Invasive VCF Repair Market in EMEA 2014-2019 ($ million)
  • Exhibit 19: Minimally Invasive VCF Repair Market in APAC 2014-2019 ($ million)
  • Exhibit 20: Segmentation of Global Minimally Invasive VCF Repair Market by Geography 2014-2019 ($ million)
  • Exhibit 21: Segmentation of Global Minimally Invasive VCF Repair Market by Geography 2014-2019
  • Exhibit 22: YOY Growth Rate Comparison of Geographical Segments with Minimally Invasive VCF Repair Market 2014-2019
  • Exhibit 23: Major Drivers of Global Minimally Invasive VCF Repair Market
  • Exhibit 24: Percentage of Elderly Aged Above 65 in Different Regions 2012 and 2050
  • Exhibit 25: Estimated Percentage of Elderly Population 2012 and 2050
  • Exhibit 26: Major Challenges in Global Minimally Invasive VCF Repair Market
  • Exhibit 27: Market Trends in Global Minimally Invasive VCF Repair Market
  • Exhibit 28: Competitive Analysis of Global Minimally Invasive VCF Repair Market 2014
  • Exhibit 29: Alphatec: Geographical Segmentation by Revenue 2014
  • Exhibit 30: CareFusion Corp.: Business Segmentation
  • Exhibit 31: CareFusion Corp.: Business Segmentation by Revenue 2012 and 2013 ($ million)
  • Exhibit 32: CareFusion Corp.: Sales by Geography 2013
  • Exhibit 33: DePuy Synthes: Business Segmentation
  • Exhibit 34: Medtronic: Key Products
  • Exhibit 35: Medtronic: Business Segmentation by Revenue 2014
  • Exhibit 36: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2014
  • Exhibit 37: Medtronic: Restorative Therapies Group Segmentation by Revenue 2014
  • Exhibit 38: Medtronic: Diabetes Group Segmentation by Revenue 2014
  • Exhibit 39: Medtronic: Business Segmentation by Revenue 2013 and 2014 ($ million)
  • Exhibit 40: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014 ($ million)
  • Exhibit 41: Medtronic: Restorative Therapies Group Segmentation by Revenue 2013 and 2014 ($ million)
  • Exhibit 42: Medtronic: Diabetes Group Segmentation by Revenue 2013 and 2014 ($ million)
  • Exhibit 43: Medtronic: Geographical Segmentation by Revenue 2014
  • Exhibit 44: Stryker: Business Segmentation by Revenue 2013
  • Exhibit 45: Stryker: Business Segmentation by Revenue 2012 and 2013 ($ million)
  • Exhibit 46: Stryker: Geographical Segmentation by Revenue 2013
  • Exhibit 47: Zimmer Holdings: Business Segmentation by Revenue 2013
  • Exhibit 48: Zimmer Holdings: Business Segmentation by Revenue 2012 and 2013 ($ billion)
  • Exhibit 49: Zimmer Holdings: Geographical Segmentation by Revenue 2013
Show More
Pricing
Back to Top